Screening for Hepatitis C Virus Infection in Adults: US Preventive Services Task Force Recommendation Statement

被引：364

作者：

Moyer, Virginia A. ^{[1
]}

机构：

[1] US Prevent Serv Task Force, Rockville, MD USA

来源：

ANNALS OF INTERNAL MEDICINE | 2013年 / 159卷 / 05期

基金：

美国医疗保健研究与质量局;

关键词：

SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; PERSONS BORN; MANAGEMENT; ASSOCIATION; ANTIBODY; FIBROSIS;

D O I：

10.7326/0003-4819-159-5-201309030-00672

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) infection in asymptomatic adults. Methods: The Agency for Healthcare Research and Quality commissioned 2 systematic reviews on screening for and treatment of HCV infection in asymptomatic adults, focusing on evidence gaps identified in the previous USPSTF recommendation and new studies published since 2004. The evidence on screening for HCV in pregnant women was also considered. Population: This recommendation applies to all asymptomatic adults without known liver disease or functional abnormalities. Recommendation: The USPSTF recommends screening for HCV infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965. (B recommendation)

引用

页码：349 / +

页数：10

共 20 条

[11] The hepatitis C self-management programme: a randomized controlled trial [J].

Groessl, E. J. ;

Weingart, K. R. ;

Stepnowsky, C. J. ;

Gifford, A. L. ;

Asch, S. M. ;

Ho, S. B. .

JOURNAL OF VIRAL HEPATITIS, 2011, 18 (05) :358-368

[12] Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials [J].

Kimer, Nina ;

Dahl, Emilie Kristine ;

Gluud, Lise Lotte ;

Krag, Aleksander .

BMJ OPEN, 2012, 2 (05)

[13] Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States [J].

Liu, Shan ;

Cipriano, Lauren E. ;

Holodniy, Mark ;

Goldhaber-Fiebert, Jeremy D. .

PLOS ONE, 2013, 8 (03)

[14] Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies [J].

Morgan, Rebecca L. ;

Baack, Brittney ;

Smith, Bryce D. ;

Yartel, Anthony ;

Pitasi, Marc ;

Falck-Ytter, Yngve .

ANNALS OF INTERNAL MEDICINE, 2013, 158 (05) :329-+

[15]

Myers RP, 2002, AM J GASTROENTEROL, V97, P2419, DOI 10.1111/j.1572-0241.2002.05997.x

[16]

Pembrey L, 2005, CLIN INFECT DIS, V41, P45, DOI 10.1086/430601

[17] The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in US Primary Care Settings [J].

Rein, David B. ;

Smith, Bryce D. ;

Wittenborn, John S. ;

Lesesne, Sarah B. ;

Wagner, Laura D. ;

Roblin, Douglas W. ;

Patel, Nita ;

Ward, John W. ;

Weinbaum, Cindy M. .

ANNALS OF INTERNAL MEDICINE, 2012, 156 (04) :263-U24

[18]

Smith BD, 2011, HEPATOLOGY, V54, p554A

[19] Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis [J].

van der Meer, Adriaan J. ;

Veldt, Bart J. ;

Feld, Jordan J. ;

Wedemeyer, Heiner ;

Dufour, Jean-Francois ;

Lammert, Frank ;

Duarte-Rojo, Andres ;

Heathcote, E. Jenny ;

Manns, Michael P. ;

Kuske, Lorenz ;

Zeuzem, Stefan ;

Hofmann, W. Peter ;

de Knegt, Robert J. ;

Hansen, Bettina E. ;

Janssen, Harry L. A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (24) :2584-2593

[20]

1998, MMWR RECOMM REP, V98, P1

← 1 2 →